Related references
Note: Only part of the references are listed.TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin
Matam Vijay-Kumar et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
Toll-Like Receptor 3 Agonist Protection against Experimental Francisella tularensis Respiratory Tract Infection
Richard B. Pyles et al.
INFECTION AND IMMUNITY (2010)
Type I IFN Signaling Constrains IL-17A/F Secretion by γδ T Cells during Bacterial Infections
Thomas Henry et al.
JOURNAL OF IMMUNOLOGY (2010)
Phagosomal retention of Francisella tularensis results in TIRAP/Mal-independent TLR2 signaling
Leah E. Cole et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses
Vijay A. K. Rathinam et al.
NATURE IMMUNOLOGY (2010)
Francisella tularensis Infection-Derived Monoclonal Antibodies Provide Detection, Protection, and Therapy
Anne G. Savitt et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
A Novel Role for Plasmin-Mediated Degradation of Opsonizing Antibody in the Evasion of Host Immunity by Virulent, but Not Attenuated, Francisella tularensis
Deborah D. Crane et al.
JOURNAL OF IMMUNOLOGY (2009)
Antigen- specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge
Leah E. Cole et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes
Araceli E. Santiago et al.
VACCINE (2009)
Administration of a synthetic TLR4 agonist protects mice from pneumonic tularemia
Annalisa Lembo et al.
JOURNAL OF IMMUNOLOGY (2008)
Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism
Kari Ann Shirey et al.
JOURNAL OF IMMUNOLOGY (2008)
Macrophage proinflammatory response to Francisella tularensis live vaccine strain requires coordination of multiple signaling pathways
Leah E. Cole et al.
JOURNAL OF IMMUNOLOGY (2008)
Recurrent systemic pneumococcal disease and IRAK4 deficiency
Stuart E. Turvey et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages
Leah E. Cole et al.
INFECTION AND IMMUNITY (2007)
Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis
Girish S. Kirimanjeswara et al.
JOURNAL OF IMMUNOLOGY (2007)
The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4
Veronica Mata-Haro et al.
SCIENCE (2007)
Recurrent infection with genetically identical pneumococcal isolates in a patient with interleukin-1 receptor-associated kinase-4 deficiency
Judit Szabo et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2007)
Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor- mediated immune responses but not in TCR signaling
Tatsukata Kawagoe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity
Tae Whan Kim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Division and differentiation of natural antibody-producing cells in mouse spleen
Yang Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease
Cheng-Lung Ku et al.
JOURNAL OF MEDICAL GENETICS (2007)
Francisella tularensis genomics and proteomics
Richard W. Titball et al.
FRANCISELLA TULARENSIS: BIOLOGY, PATHOGENICITY, EPIDEMIOLOGY, AND BIODEFENSE (2007)
Contribution of interferon-β to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide
Karen E. Thomas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Chromosome rearrangement and diversification of Francisella tularensis revealed by the type B (OSU18) genome sequence
Joseph F. Petrosino et al.
JOURNAL OF BACTERIOLOGY (2006)
Immunologic consequences of Francisella tularensis live vaccine strain infection:: Role of the innate immune response in infection and immunity
Leah E. Cole et al.
JOURNAL OF IMMUNOLOGY (2006)
Toll-like receptor 2 is required for control of pulmonary infection with Francisella tularensis
Meenakshi Malik et al.
INFECTION AND IMMUNITY (2006)
Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVS
J Katz et al.
INFECTION AND IMMUNITY (2006)
A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei
DM Waag et al.
INFECTION AND IMMUNITY (2006)
Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice
G Hartley et al.
VACCINE (2006)
Francisella tularensis enters macrophages via a novel process involving pseudopod loops
DL Clemens et al.
INFECTION AND IMMUNITY (2005)
Structural analysis of the O-antigen of Francisella tularensis subspecies tularensis strain OSU 10
NR Thirumalapura et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2005)
STAT signaling underlies difference between flagellin-induced and tumor necrosis factor-α-induced epithelial gene expression
YM Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei
S Wongratanacheewin et al.
INFECTION AND IMMUNITY (2004)
Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents
JR Baldridge et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Regulation of phagosome maturation by signals from Toll-like receptors
JM Blander et al.
SCIENCE (2004)
Characterization of the O antigen gene cluster and structural analysis of the O antigen of Francisella tularensis subsp tularensis
JL Prior et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2003)
Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections
AE Medvedev et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Pyogenic bacterial infections in humans with IRAK-4 deficiency
C Picard et al.
SCIENCE (2003)
Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain
KL Elkins et al.
MICROBES AND INFECTION (2003)
Mice intradermally-inoculated with the intact lipopolysaccharide, but not the lipid A or O-chain, from Francisella tularensis LVS rapidly acquire varying degrees of enhanced resistance against systemic or aerogenic challenge with virulent strains of the pathogen
JW Conlan et al.
MICROBIAL PATHOGENESIS (2003)
Taking toll: lipid A mimetics as adjuvants and immunomodulators
DH Persing et al.
TRENDS IN MICROBIOLOGY (2002)
Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis
M Fulop et al.
VACCINE (2001)
Tularemia as a biological weapon - Medical and public health management
DT Dennis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
F Hayashi et al.
NATURE (2001)
Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon
VC Dreisbach et al.
INFECTION AND IMMUNITY (2000)
Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme
M Muramatsu et al.
CELL (2000)
Share Paper
